Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Assets Average (2019 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Assets Average for 7 consecutive years, with $798.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average fell 22.3% year-over-year to $798.1 million, compared with a TTM value of $798.1 million through Sep 2025, down 22.3%, and an annual FY2024 reading of $776.1 million, up 54.3% over the prior year.
  • Assets Average was $798.1 million for Q3 2025 at Bicycle Therapeutics, down from $858.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $1.0 billion in Q3 2024 and bottomed at $192.5 million in Q1 2021.
  • Average Assets Average over 5 years is $568.3 million, with a median of $469.7 million recorded in 2022.
  • The sharpest move saw Assets Average surged 143.99% in 2022, then decreased 22.3% in 2025.
  • Year by year, Assets Average stood at $380.6 million in 2021, then increased by 8.75% to $413.9 million in 2022, then soared by 49.08% to $617.0 million in 2023, then soared by 58.31% to $976.8 million in 2024, then decreased by 18.3% to $798.1 million in 2025.
  • Business Quant data shows Assets Average for BCYC at $798.1 million in Q3 2025, $858.0 million in Q2 2025, and $920.4 million in Q1 2025.